Global Colon Cancer Association

Advocating for patient-centered policy - the gcca is a leader in the international policy arena, representing more than 6,000,000 colorectal cancer patients around the world. The gcca invests substantial time in representing the patient perspective to regulators, policymakers and other relevant stakeholders, including the fda, ema, who and other governing bodies wherever possible. The gcca's policy travel expenses are paid by other coalitions so the organization does not incur a great deal of expenses in comparison to the amount of work performed.

Education - addressing the needs of the colon cancer community and the general public is the key to tackling the problems associated with colon cancer. With the disease being the most preventable major cancer through screening, educating people about screenings is a major mission of the gcca and all of its members. In 2024, we held our 5th annual colorectal cancer congress, which provided critical disease education. Our know your biomarker program expanded in content and reach, as well as our clinical trial awareness program to increase participation and understanding of clinical trials. Further, the gcca attends major oncology and gastroenterology conferences where we frequently are also invited to speak, present, or otherwise educate the patient advocate community. Lastly, the gcca educates through social media and other programs we currently have where we provide forums for patient education and information exchange among patients.